SCHEMBL6284103

SCHEMBL6284103

CC(C)(C)OC(=O)N(Cc1cccc(Cl)c1)c1cncc(N2CCNCC2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 9/20 0.53
HTR2A P28223 5/20 0.53
HTR2B P41595 3/20 0.53
HTR1A P08908 3/20 0.52
HTR7 P34969 2/20 0.52
CHRM4 P08173 1/20 0.52
ADRB1 P08588 1/20 0.52
CHRM5 P08912 1/20 0.52
CHRM1 P11229 1/20 0.52
CHRM3 P20309 1/20 0.52
FPR3 P25089 1/20 0.52
HTR1D P28221 1/20 0.52
HTR1B P28222 1/20 0.52
HTR1E P28566 1/20 0.52
GPR183 P32249 1/20 0.52
HRH1 P35367 1/20 0.52
DRD3 P35462 1/20 0.52
HTR3A P46098 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
GPR35 Q9HC97 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6285560 0.90 HTR2C (0.45) HTR2CHTR2AHTR2BHTR1AHTR7
SCHEMBL905862 0.87 HTR2C (0.56) HTR2CHTR2AHTR2BHTR1AHTR7
SCHEMBL6284840 0.85 HTR2C (0.51) HTR2CHTR2AHTR2BHTR1AHTR7
SCHEMBL6285584 0.82 MAPKAPK2 (0.41) HTR2CHTR2AHTR2BHTR1AHTR7
SCHEMBL6286764 0.82 RIPK1 (0.42) HTR2CMAOBKDM4ERIPK1
SCHEMBL6284131 0.82 CKS1B (0.44) HTR2CHTR2AHTR2BHTR1AHTR7
SCHEMBL6278048 0.81 HTR2C (0.40) HTR2CHTR2AHTR2BHTR1AHTR7
SCHEMBL6284845 0.73 HDAC1 (0.41) CHRM1CHRM3MEN1ALDH1A1KMT2A
SCHEMBL6332649 0.70 HTR2C (0.45) HTR2CHTR2AHTR2BHTR1AHTR7
SCHEMBL31498036 0.70 HTR2C (1.00) HTR2CHTR2AHTR2BHTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6894050-B2 5-HT receptor ligands and uses thereof PFIZER INC. (US) 2005-05-17 US disclosed
US-20050090503-A1 5-HT receptor ligands and uses thereof PFIZER INC 2005-04-28 US disclosed
US-20050020604-A1 5-HT receptor ligands and uses thereof PFIZER INC 2005-01-27 US disclosed
US-20030125334-A1 5-HT receptor ligands and uses thereof CHIANG PHOEBE (US) 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090503-A1 5-HT receptor ligands and uses thereof HTR2A, HTR1A, HTR5A HTR2C 4/4885HTR2A 1/4885HTR2B 5/4885
US-20050020604-A1 5-HT receptor ligands and uses thereof HTR2A, HTR1A, HTR5A HTR2C 4/4885HTR2A 1/4885HTR2B 5/4885
US-20030125334-A1 5-HT receptor ligands and uses thereof HTR1A, HTR2A, HTR5A HTR2C 4/4885HTR2A 2/4885HTR2B 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.